Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 354 Lymphoma 306 Lymphoma, Follicular 268 Lymphoma, Non-Hodgkin 170 Leukemia 138 Hodgkin Disease 135 Multiple Myeloma 130 Leukemia, Lymphocytic, Chronic, B-Cell 110 Lymphoma, Large B-Cell, Diffuse 108 Leukemia, Myeloid, Acute 98 Neoplasms 83 Lymphoma, Mantle-Cell 70 Burkitt Lymphoma 70 Myelodysplastic Syndromes 64 Breast Neoplasms 62 Lymphoma, T-Cell, Cutaneous 60 Lymphoma, B-Cell, Marginal Zone 59 Myeloproliferative Disorders 50 Mycosis Fungoides 50 Motor Activity 49 Lymphoma, Large-Cell, Immunoblastic 47 Sezary Syndrome 44 Neoplasms, Plasma Cell 42 Hematologic Neoplasms 41 Dementia 41 Primary Myelofibrosis 39 Leukemia, Myeloid, Chronic-Phase 38 Leukemia, Myeloid, Accelerated Phase 38 Congenital Abnormalities 38 Recurrence 37

Interventions

Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Anosmia × Lymphoid × Clear all

NCT04716153 2026-01-20

RE-NEZ-SENS

University Hospital, Montpellier

Phase NA Terminated

LymphoidPlasma cell

Anosmia, Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡